Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

PHUC NGUYEN

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1881798270
CMS profile
175846
Location
BURLESON, TX

General Payments · PY2018–2024

$3,361.53

  • Reported across 144 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$450.06

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $425.45 15
Education $24.61 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $331.69 8
PY2019 $116.60 7
PY2020 $125.92 7
PY2021 $529.91 22
PY2022 $942.70 44
PY2023 $864.65 40
PY2024 $450.06 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AKEBIA THERAPEUTICS INC $24.61 09/12/2024 Education Undisputed 01/23/2026 1145833301 CMS
Alexion Pharmaceuticals, Inc. $25.45 09/04/2024 Food and Beverage Undisputed 01/23/2026 1093999631 CMS
Amgen Inc. $23.81 05/23/2024 Food and Beverage Undisputed 01/23/2026 1115968728 CMS
Amgen Inc. $13.54 11/18/2024 Food and Beverage Undisputed 01/23/2026 1115968736 CMS
Amgen Inc. $135.66 12/05/2024 Food and Beverage Undisputed 01/23/2026 1117640451 CMS
AstraZeneca Pharmaceuticals LP $19.37 04/11/2024 Food and Beverage Undisputed 01/23/2026 1105375414 CMS
Bayer Healthcare Pharmaceuticals Inc. $13.07 02/13/2024 Food and Beverage Undisputed 01/23/2026 1086153135 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.75 07/04/2024 Food and Beverage Undisputed 01/23/2026 1086109592 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.30 12/04/2024 Food and Beverage Undisputed 01/23/2026 1086121284 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.61 06/12/2024 Food and Beverage Undisputed 01/23/2026 1118213474 CMS
Lilly USA, LLC $25.90 11/21/2024 Food and Beverage Undisputed 01/23/2026 1135319697 CMS
Mallinckrodt Hospital Products Inc. $27.61 06/20/2024 Food and Beverage Undisputed 01/23/2026 1145113074 CMS
Novartis Pharmaceuticals Corporation $24.67 08/28/2024 Food and Beverage Undisputed 01/23/2026 1087146640 CMS
Novartis Pharmaceuticals Corporation $14.13 12/18/2024 Food and Beverage Undisputed 01/23/2026 1087146644 CMS
OPKO Pharmaceuticals, LLC $20.50 11/20/2024 Food and Beverage Undisputed 01/23/2026 1112847834 CMS
Vifor Pharma, Inc. $28.08 01/03/2024 Food and Beverage Undisputed 01/23/2026 1124035026 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.